Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis B

Clinical trial condition

Hepatitis B

Explore clinical trials studying Hepatitis B. Study availability and eligibility vary by location and protocol.

720 public trials 60 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis B trial results

Completed

Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine

NCT01453348

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +27 more
Locations: 03, Novartis Investigational Site Berlin, Germany

02, Novartis Investigational Site Hamburg, Germany

01, Novartis Investigational Site München, Germany

04, Novartis Investigational Site Rostock, Germany

View Trial Details

Completed

Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths

NCT00158808

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +21 more
Locations: GSK Investigational Site City of Muntinlupa, Philippines

View Trial Details

Completed

Immunogenicity and Safety of an Adjuvanted HBV Vaccine Compared to Engerix™-B, in a Non-responder Population ≥ 15y

NCT00698061

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Not specified

View Trial Details

Completed

Community-based Hepatitis B Interventions for Hmong Adults

NCT00888407

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +13 more
Locations: UC Davis Cancer Center Sacramento, California, United States

View Trial Details

Completed

Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers

NCT02153320

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Investigational Site Brussels, Belgium

GSK Investigational Site Ghent, Belgium

View Trial Details

Completed

A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057)

NCT00414050

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Not specified

View Trial Details

Completed

Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of Age

NCT01470287

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +23 more
Locations: Rajarajeshwari Medical College and Hospital Bangalore, Karnataka, India

Bharathi Vidyapeeth University Pune, Maharashtra, India

Medical College Kolkata Kolkata, West Bengal, India

View Trial Details

Completed

Program of Screening, Prevention and Elimination of Hepatitis C in Penitentiary Institutions in Cantabria (JAILFREE-C)

NCT02768961

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +11 more
Locations: Penitentiary "El Dueso". Cantabria. Spain Santoña, Cantabria, Spain

View Trial Details

Completed

Blood-borne Infection Screening in an Afghan Antenatal Population

NCT01199601

Conditions: Behavior, Blood-Borne Infections, Breast Feeding, +15 more
Locations: Maternity Hospitals Kabul, Afghanistan

View Trial Details

Completed

DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants

NCT02094833

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +36 more
Locations: Daejeon, South Korea

Gyeonggi-do, South Korea

Gyeonggi-do, South Korea

Gyeongsangnam Do, South Korea

View all 16 locations

View Trial Details